Smith & Nephew plc (SNN) News
Track canonical SquawkNews coverage tagged to SNN, Smith & Nephew plc. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Smith & Nephew prices cash tender offer for $250m 2030 bonds
Smith+Nephew priced its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030.
MACRO | Sep 15, 2026, 10:03 PM UTC
H
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it w
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it was likely to miss its FY26 and Q3 adjusted EPS and net sales growth guidance fol
EARNINGS | Sep 08, 2026, 04:05 PM UTC
M
Romania’s Nuclearelectrica reactors likely off for September
Romanian state power producer Nuclearelectrica says two reactors will likely remain turned off throughout September due to low Danube river water levels, per a deputy energy minister.
EQUITY | Sep 08, 2026, 03:17 PM UTC
L
Smith+Nephew launches cash tender offer for up to $250m 2030 notes
Smith+Nephew announced a cash tender offer to purchase for cash up to $250 million of its outstanding 2.032% notes due 2030.
EQUITY | Sep 08, 2026, 12:40 PM UTC
H
Analyst actions: MDT Buy target raised; SNN rating changes; GSK plan disclosed
Analyst updates: MDT maintained Buy and raised price target to $110; SNN Hold and coverage notes; GSK Underweight downgrade. Separately, GSK plans a September Phase 3 mRNA flu trial.
EARNINGS | Sep 08, 2026, 11:33 AM UTC
L
Smith+Nephew CFO John Rogers to step down Sept. 30
Smith+Nephew says CFO John Rogers informed the Board he intends to leave his CFO role on 30 September and step down from the Board with immediate effect, with a successor search initiated.
EQUITY | Aug 19, 2026, 10:44 AM UTC
L
Smith+Nephew and Imperial College launch surgical robotics innovation centre
Smith+Nephew (SNN) and Imperial College London launch a centre aimed at accelerating innovation in surgical robotics, according to TradeXchange Newsdesk.
EQUITY | Aug 18, 2026, 07:01 AM UTC
M
Smith+Nephew launches FLOW FLEXTEND COBLATION Wand for complex hip
Smith+Nephew (SNN) is promoting its new FLOW FLEXTEND™ COBLATION™ Wand, saying it improves access and resection efficiency for complex hip procedures versus fixed-angle options, without supplying quantitative results or
EQUITY | Aug 17, 2026, 12:00 PM UTC
L
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks Moving Lower In Tuesday’s Pre-Marke
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Tuesday. Shares of Powell Industries Inc (NASDAQ: POWL ) fell sharply in pre-market trading after the company reported
EARNINGS | Aug 04, 2026, 12:04 PM UTC
L
CORRECTION: Smith & Nephew Lowers FY2026 Sales Guidance from $6.534B to $6.411B vs $6.565B Est
Smith & Nephew (NYSE: SNN ) lowers FY2026 sales outlook from $6.534 billion to $6.411 billion vs $6.565 billion estimate.
EARNINGS | Aug 04, 2026, 11:54 AM UTC
L
Smith & Nephew Lowers FY2026 Sales Guidance from $6B to $6B vs $1.602B Est
Smith & Nephew (NYSE: SNN ) lowers FY2026 sales outlook from $6Billion to $6Billion vs $1.602 billion estimate.
EARNINGS | Aug 04, 2026, 10:15 AM UTC
L
SNN - Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine
SNN - Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
REGULATION | Jul 29, 2026, 02:00 PM UTC
L
Smith & Nephew shares are trading higher. The company announced it has applied to list 150,000 ordinary shares on the LSE, with admission ex
Smith & Nephew shares are trading higher. The company announced it has applied to list 150,000 ordinary shares on the LSE, with admission expected July 6, under a block admission tied to employee share plans.
EQUITY | Jul 02, 2026, 05:46 PM UTC